A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia - Concepedia

Concepedia

Publication | Closed Access

A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia

324

Citations

5

References

2001

Year

Wayne S. Fenton, Faith Dickerson, John J. Boronow, Joseph R. Hibbeln, Michael B. Knable

American Journal of Psychiatry

Abstract

For schizophrenia patients treated with 3 g/day of ethyl EPA, improvement in residual symptoms and cognitive impairment was no greater than for schizophrenia patients treated with placebo.

References

	Year	Citations

Page 1